Housman T Salam, Pearce D J, Feldman S R
Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
J Dermatolog Treat. 2004 Apr;15(2):94-7. doi: 10.1080/09546630310021947.
Using the 308 nm excimer laser, to evaluate the effectiveness of tapering the dose frequency on maintaining the clearance of psoriasis plaques after at least 75% clearance of a target plaque was achieved.
This prospective case series, conducted at a university-based dermatology practice, enrolled five adults with stable, mild-to-moderate plaque-type psoriasis vulgaris. Patients received 308 nm UVB doses to affected areas. Initial dosing was based on multiples of a pre-determined minimal erythema dose (MED). Delivered fluences were 100, 150, 200, 250, 300 and 350 mJ/cm(2), corresponding to MED levels of 1 through 6. Subsequent doses were based on response to treatment. Induction treatments were scheduled biweekly for a total of 15 treatments. After improvement of disease, tapering began as follows: one treatment per week for 4 weeks, one treatment every other week for 4 weeks, and one final treatment 4 weeks later for a total of seven treatments. The main outcome measure was maintenance of disease improvement as determined by the Psoriasis Area and Severity Index (PASI) score and percentage improvement of target lesion and total body disease during and after the laser therapy taper. A flare was defined as a 25% worsening of the percentage improvement.
All five patients completed the protocol. All patients achieved > or = 75% clearance of target plaques. No flares were noted upon completing the first month of the taper in any patient, either per percentage improvement or per PASI scores. One month after the second month of the taper (total of six treatments), no flares were noted and four out of five patients had no flares per PASI scores. No patients, either at the end of induction or at any interval during the taper, met the definition of a 50% rebound of PASI scores. Adverse effects included erythema, blisters, hyperpigmentation and erosions. All were well tolerated.
Our results reaffirm that biweekly UVB laser treatments promote clearance of psoriatic plaques. A tapering of laser treatments may be beneficial in maintaining the level of plaque clearance obtained from biweekly laser treatments. Randomized, prospective trials are needed to establish laser therapy protocols for maintaining the plaque clearance achieved with the 308 nm excimer laser.
使用308纳米准分子激光,评估在目标斑块至少清除75%后,逐渐减少给药频率对维持银屑病斑块清除效果的有效性。
本前瞻性病例系列研究在一家大学皮肤科诊所进行,纳入了5名患有稳定的轻至中度寻常型斑块状银屑病的成年人。患者接受308纳米UVB照射受影响区域。初始剂量基于预先确定的最小红斑量(MED)的倍数。给予的能量密度为100、150、200、250、300和350 mJ/cm²,分别对应MED水平1至6。后续剂量根据治疗反应而定。诱导治疗计划每两周进行一次,共15次治疗。疾病改善后,逐渐减量如下:每周一次治疗,共4周;每两周一次治疗,共4周;4周后进行最后一次治疗,共7次治疗。主要观察指标是通过银屑病面积和严重程度指数(PASI)评分以及激光治疗减量期间和之后目标皮损和全身疾病改善百分比来确定疾病改善的维持情况。病情复发定义为改善百分比恶化25%。
所有5名患者均完成了方案。所有患者的目标斑块清除率均达到≥75%。在减量的第一个月结束时,无论根据改善百分比还是PASI评分,任何患者均未出现病情复发。在减量的第二个月结束后1个月(共6次治疗),未观察到病情复发,5名患者中有4名根据PASI评分未出现病情复发。在诱导结束时或减量期间的任何时间点,均无患者达到PASI评分50%反弹的定义。不良反应包括红斑、水疱、色素沉着和糜烂。所有不良反应均耐受性良好。
我们的数据再次证实,每两周一次的UVB激光治疗可促进银屑病斑块的清除。逐渐减少激光治疗剂量可能有助于维持每两周一次激光治疗所获得的斑块清除水平。需要进行随机前瞻性试验来建立维持308纳米准分子激光所达到的斑块清除效果的激光治疗方案。